Presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
- June 7, 2021
- Julie Ha
Abstract Title: BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7/8) agonist, in combination with pembrolizumab in advanced solid tumors: Phase 1 safety and efficacy results.
Abstract Authors: Manish R. Patel, Anthony W. Tolcher, Drew W. Rasco, Melissa Lynne Johnson, Angela Tatiana Alistar, Lixin Li, Alexander H. Chung, Robert H.I. Andtbacka
Session Title: Poster Discussion Session, Developmental Therapeutics—Immunotherapy
On-Demand Session Release Date and Time: 6/4/2021, 9:00 AM-10:00 AM
Abstract Number: 2512
Presentation Materials:
Full Presentation: available on the ASCO Meeting Library
Abstract Title: BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7/8) agonist, in combination with pembrolizumab in advanced solid tumors: Phase 1 safety and efficacy results.
Abstract Authors: Manish R. Patel, Anthony W. Tolcher, Drew W. Rasco, Melissa Lynne Johnson, Angela Tatiana Alistar, Lixin Li, Alexander H. Chung, Robert H.I. Andtbacka
Session Title: Poster Discussion Session, Developmental Therapeutics—Immunotherapy
On-Demand Session Release Date and Time: 6/4/2021, 9:00 AM-10:00 AM
Abstract Number: 2512
Presentation Materials:
Full Presentation: available on the ASCO Meeting Library